Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Critical Care (London, England)|January 15, 2008
RAGE: exacting a toll on the host in response to polymicrobial sepsis and Listeria monocytogenesRaphael Clynes, Kevan Herold, Ann Marie SchmidtNature|May 1, 2010
Genetics, pathogenesis and clinical interventions in type 1 diabetesJeffrey A Bluestone, Kevan Herold, George EisenbarthNature Reviews. Immunology|November 6, 2007
Type 1 diabetes as a relapsing-remitting disease?Matthias von Herrath, Srinath Sanda, Kevan HeroldThe Diabetes Educator|February 21, 2002
Increasing problem solving in adolescents with type 1 diabetes: the choices diabetes programSandy Cook, Kevan Herold, Deborah V Edidin, et al.Annals of the New York Academy of Sciences|May 2, 2008
Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosisRavichandran Ramasamy, Shi Fang Yan, Kevan Herold, et al.Endocrinology and Metabolism Clinics of North America|September 9, 2006
Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEingShi Fang Yan, Shi Du Yan, Kevan Herold, et al.Current Molecular Medicine|March 12, 2008
Receptor for AGE (RAGE): weaving tangled webs within the inflammatory responseRaphael Clynes, Bernhard Moser, Shi Fang Yan, et al.Glycobiology|March 15, 2005
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammationRavichandran Ramasamy, Susan J Vannucci, Shirley Shi Du Yan, et al.Current Atherosclerosis Reports|April 28, 2006
The ligand/RAGE axis: lighting the fuse and igniting vascular stressShi Fang Yan, Yoshifumi Naka, Barry I Hudson, et al.Biochemical and Biophysical Research Communications|February 1, 2006
Expansion and redifferentiation of adult human pancreatic islet cellsLimor Ouziel-Yahalom, Michal Zalzman, Leeat Anker-Kitai, et al.Pageof 3